AGP Picks
View all

Global Healthcare Today
Provided by AGP

Global Healthcare Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Global Healthcare Today.

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

July 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

Press releases published on May 27, 2026

Context Therapeutics to Present at the Jefferies Global Healthcare Conference
May 27, 2026

Context Therapeutics to Present at the Jefferies Global Healthcare Conference

Indeterminate GlobeNewswire
TG Therapeutics Announces Positive Topline Results from Phase 3 ENHANCE Trial
May 27, 2026

TG Therapeutics Announces Positive Topline Results from Phase 3 ENHANCE Trial

Indeterminate GlobeNewswire
Palvella Therapeutics Strengthens QTORIN™ Pitavastatin Intellectual Property with Yale-Licensed U.S. Patent Providing Protection into 2043
May 27, 2026

Palvella Therapeutics Strengthens QTORIN™ Pitavastatin Intellectual Property with Yale-Licensed U.S. Patent Providing Protection into 2043

Indeterminate GlobeNewswire
Jupiter Neurosciences Announces Patient Enrollment Underway in Phase 2a RESET Trial in Parkinson’s Disease
May 27, 2026

Jupiter Neurosciences Announces Patient Enrollment Underway in Phase 2a RESET Trial in Parkinson’s Disease

Indeterminate GlobeNewswire
Reprogram Biosciences Closes Seed Financing to Advance Tumor Cell Reprogramming Therapeutics
May 27, 2026

Reprogram Biosciences Closes Seed Financing to Advance Tumor Cell Reprogramming Therapeutics

Indeterminate GlobeNewswire
Maze Therapeutics to Participate in Two Upcoming Investor Conferences
May 27, 2026

Maze Therapeutics to Participate in Two Upcoming Investor Conferences

Indeterminate GlobeNewswire
Invivyd to Participate in Upcoming Investor Events
May 27, 2026

Invivyd to Participate in Upcoming Investor Events

Indeterminate GlobeNewswire
MitoRx Therapeutics to present new preclinical data on MTRX31, its novel mitochondrial-targeted small molecule at the American Diabetes Association’s 2026 Scientific Sessions
May 27, 2026

MitoRx Therapeutics to present new preclinical data on MTRX31, its novel mitochondrial-targeted small molecule at the American Diabetes Association’s 2026 Scientific Sessions

Indeterminate GlobeNewswire
Balchem Corporation to Participate in the Wells Fargo Industrials Conference on June 10, 2026
May 27, 2026

Balchem Corporation to Participate in the Wells Fargo Industrials Conference on June 10, 2026

Indeterminate GlobeNewswire
L’Association canadienne de dermatologie, en partenariat avec Mélanome Canada, offrira des dépistages gratuits du cancer de la peau sur la Colline du Parlement
May 27, 2026

L’Association canadienne de dermatologie, en partenariat avec Mélanome Canada, offrira des dépistages gratuits du cancer de la peau sur la Colline du Parlement

Indeterminate GlobeNewswire
Canadian Dermatology Association in Partnership with Melanoma Canada Offer Free Skin Cancer Screenings on Parliament Hill
May 27, 2026

Canadian Dermatology Association in Partnership with Melanoma Canada Offer Free Skin Cancer Screenings on Parliament Hill

Indeterminate GlobeNewswire
Kymera Therapeutics to Participate in Fireside Chat at the Jefferies Global Healthcare Conference
May 27, 2026

Kymera Therapeutics to Participate in Fireside Chat at the Jefferies Global Healthcare Conference

Indeterminate GlobeNewswire
Tonix Pharmaceuticals Announces Publication of Phase 1 Clinical Data of TNX-1500, an Fc-Modified anti-CD40L (CD154) Monoclonal Antibody, in the Peer-Reviewed Journal of Clinical Immunology
May 27, 2026

Tonix Pharmaceuticals Announces Publication of Phase 1 Clinical Data of TNX-1500, an Fc-Modified anti-CD40L (CD154) Monoclonal Antibody, in the Peer-Reviewed Journal of Clinical Immunology

Indeterminate GlobeNewswire
Satellos to Participate in Upcoming Investor Conferences
May 27, 2026

Satellos to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire
Atea Pharmaceuticals Presents New Drug-Drug Interaction Results Supporting Potential Best-in-Class Profile of the Regimen of Bemnifosbuvir and Ruzasvir for the Treatment of Hepatitis C Virus at EASL Congress 2026
May 27, 2026

Atea Pharmaceuticals Presents New Drug-Drug Interaction Results Supporting Potential Best-in-Class Profile of the Regimen of Bemnifosbuvir and Ruzasvir for the Treatment of Hepatitis C Virus at EASL Congress 2026

Indeterminate GlobeNewswire
Axsome Therapeutics to Participate in Upcoming Investor Conferences
May 27, 2026

Axsome Therapeutics to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire
BrewDog Turns This Summer’s Global Football Tournament into a Nationwide Celebration of Beer, Bars and Big Match Moments
May 27, 2026

BrewDog Turns This Summer’s Global Football Tournament into a Nationwide Celebration of Beer, Bars and Big Match Moments

Indeterminate GlobeNewswire
LeonaBio to Participate in Upcoming Medical and Industry Meetings in June
May 27, 2026

LeonaBio to Participate in Upcoming Medical and Industry Meetings in June

Indeterminate GlobeNewswire
Sagimet Biosciences Presents Two Posters at EASL 2026 on Denifanstat/Resmetirom Combination in MASH
May 27, 2026

Sagimet Biosciences Presents Two Posters at EASL 2026 on Denifanstat/Resmetirom Combination in MASH

Indeterminate GlobeNewswire
Harrow to Present at William Blair’s 46th Annual Growth Stock Conference
May 27, 2026

Harrow to Present at William Blair’s 46th Annual Growth Stock Conference

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Global Healthcare Today

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.